1 / 18

Table of Content - Global Digital PCR Market

The global digital PCR market is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022-2032.

bisreports
Télécharger la présentation

Table of Content - Global Digital PCR Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. res Global Digital PCR Market - A Region and Country Analysis Table of Content Focus on Product, Application Type, End User, and Region Global Digital PCR Market Analysis and Forecast: 2022-2032 August 2022 1 All rights reserved at BIS Research Inc.

  2. BIS Research is a leading market intelligence and technology research company. BIS Research publishes in- depth market intelligence reports focusing on the market estimations, technology analysis, emerging high- growth applications, deeply segmented granular country-level market data and other important market parameters useful in the strategic decision making for senior management. BIS Research provides multi-client reports, company profiles, databases, and custom research services. Copyright © 2022 BIS Research Inc. Global Digital PCR Market All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all contents of this document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It may not be accessed by or offered whether for sale or otherwise to any third party. 2 All rights reserved at BIS Research Inc.

  3. Table of Content Executive Summary .......................................................................... 19 1.Markets ..................................................................................... 23 1.1 Product Definition ....................................................................................... 24 1.1.1Inclusion and Exclusion ............................................................................. 24 1.2 Market Scope ............................................................................................... 25 1.2.1Scope of Work ............................................................................................. 25 1.2.2Key Questions Answered in the Report .................................................... 26 2.Research Methodology .............................................................. 27 2.1 Global Digital PCR Market: Research Methodology ................................. 28 2.2 Data Sources ............................................................................................... 28 2.2.1Primary Data Sources ................................................................................. 28 2.2.2Secondary Data Sources ............................................................................ 29 2.3 Market Estimation Model ............................................................................ 30 2.4 Criteria for Company Profiling ................................................................... 32 3.Market Overview ........................................................................ 33 3.1 Market Definition ......................................................................................... 34 3.2 d-PCR vs. qPCR .......................................................................................... 34 3.3 Market Footprint and Growth Potential ..................................................... 35 3.4 COVID-19 Impact on the Global Digital PCR Market ................................ 36 3.4.1Impact on Research and Clinical Operations ........................................... 36 3.4.2Impact on Market Players ........................................................................... 37 Global Digital PCR Market 3.4.3Impact on Market Growth ........................................................................... 38 4. Industry Analysis ...................................................................... 39 4.1 Overview ...................................................................................................... 40 4.1.1Regulatory Framework in the U.S. ............................................................. 40 4.1.2Regulatory Framework in European Union (EU) ....................................... 41 3 All rights reserved at BIS Research Inc.

  4. 4.1.3Regulatory Framework in Asia-Pacific ...................................................... 42 4.1.3.1 Japan ................................................................................................................. 42 4.1.3.2 China ................................................................................................................. 43 4.2 Patent Analysis ............................................................................................ 44 4.2.1Patent Analysis (by Region) ....................................................................... 45 4.2.2Patent Analysis (by Country) ..................................................................... 45 4.2.3Patent Analysis (by Year) ........................................................................... 46 5.Market Dynamics ....................................................................... 47 5.1 Overview ...................................................................................................... 48 5.2 Impact Analysis ........................................................................................... 48 5.2.1Market Drivers ............................................................................................. 49 5.2.1.1 Technological Transformations Related to Digital PCR ..................................... 49 5.2.1.2 Rising Adoption of Digital PCR among Various Applications ............................ 50 5.2.1.3 Increasing Activities in d-PCR Ecosystem ......................................................... 52 5.2.2Market Restraints ........................................................................................ 53 5.2.2.1 Higher Cost of Droplet Digital PCR .................................................................... 53 5.2.2.2 Presence of Opaque Regulatory Framework .................................................... 53 5.2.3Market Opportunities .................................................................................. 54 5.2.3.1 Extensive Adoption of Genetic Testing, especially in Developing Nations ........ 54 5.2.3.2 Increasing Adoption of d-PCR in Chronic Disease Diagnosis ........................... 54 6. Competitive Landscape ............................................................. 56 6.1 Competitive Landscape .............................................................................. 57 6.1.1Mergers and Acquisitions ........................................................................... 58 6.1.2Synergistic Activities .................................................................................. 58 Global Digital PCR Market 6.1.3Product Launch and Approval Activities .................................................. 59 6.1.4Expansion, Funding, and Other Activities ................................................ 60 6.1.5Market-Share Analysis ................................................................................ 61 6.1.6Growth-Share Analysis ............................................................................... 62 4 All rights reserved at BIS Research Inc.

  5. 6.1.6.1 Growth-Share Analysis (by Company) .............................................................. 62 6.1.6.2 Growth-Share Analysis (by Application Type) ................................................... 63 6.2 Supply Chain Analysis ................................................................................ 64 7. Product ..................................................................................... 66 7.1 Overview ...................................................................................................... 67 7.1.1Systems ........................................................................................................ 68 7.1.1.1 Droplet Digital PCR Systems ............................................................................. 70 7.1.1.2 Chip-Based Digital PCR Systems ...................................................................... 72 7.1.2Kits and Assays ........................................................................................... 74 7.1.2.1 Droplet Digital PCR Systems ............................................................................. 77 7.1.2.2 Chip-Based Digital PCR .................................................................................... 77 7.1.3Reagents and Consumables ...................................................................... 78 7.1.3.1 Droplet Digital PCR ............................................................................................ 80 7.1.3.2 Chip-Based Digital PCR .................................................................................... 80 8. Application Type ....................................................................... 81 8.1 Overview ...................................................................................................... 82 8.1.1Oncology ...................................................................................................... 83 8.1.1.1 Solid Tumor ....................................................................................................... 85 8.1.1.2 Hematological Malignancies .............................................................................. 86 8.1.2Infectious Diseases ..................................................................................... 87 8.1.2.1 Respiratory Infections ........................................................................................ 88 8.1.2.2 Gastrointestinal Infections ................................................................................. 89 8.1.2.3 Other Infectious Diseases .................................................................................. 90 8.1.3Rare Diseases .............................................................................................. 91 Global Digital PCR Market 8.1.3.1 Inherited Trait Type ............................................................................................ 93 8.1.3.2 Acquired Trait Type ........................................................................................... 93 8.1.4Reproductive Genetics ............................................................................... 94 8.1.4.1 Prenatal Diseases .............................................................................................. 95 5 All rights reserved at BIS Research Inc.

  6. 8.1.4.2 Postnatal Diseases ............................................................................................ 95 8.1.5Gene Expression ......................................................................................... 96 8.1.6Other Applications ...................................................................................... 97 9. End User ................................................................................... 98 9.1 Overview ...................................................................................................... 99 9.1.1Academic and Research Institutions ....................................................... 100 9.1.2Hospitals and Clinics ................................................................................ 101 9.1.3Diagnostic Centers .................................................................................... 102 9.1.4Biopharmaceutical Companies ................................................................ 102 10.Region ..................................................................................... 104 10.1 Overview .................................................................................................... 105 10.2 North America ............................................................................................ 109 10.2.1 U.S. ....................................................................................................... 111 10.2.2 Canada ................................................................................................. 112 10.3 Europe ........................................................................................................ 116 10.3.1 Germany ............................................................................................... 118 10.3.2 France .................................................................................................. 119 10.3.3 U.K. ....................................................................................................... 121 10.3.4 Italy ....................................................................................................... 122 10.3.5 Spain .................................................................................................... 124 10.3.6 Rest-of-Europe .................................................................................... 125 10.4 Asia-Pacific ................................................................................................ 129 10.4.1 Japan .................................................................................................... 131 Global Digital PCR Market 10.4.2 China .................................................................................................... 132 10.4.3 Australia ............................................................................................... 134 10.4.4 South Korea ......................................................................................... 135 10.4.5 Rest of Asia-Pacific ............................................................................. 137 10.5 Latin America............................................................................................. 139 6 All rights reserved at BIS Research Inc.

  7. 10.5.1 Brazil .................................................................................................... 141 10.5.2 Mexico .................................................................................................. 142 10.5.3 Rest-of-Latin America ......................................................................... 144 10.6 Rest-of-the-World (RoW) .......................................................................... 145 10.6.1 Middle East .......................................................................................... 146 10.6.1.1 K.S.A. ............................................................................................................... 147 10.6.1.2 Egypt ................................................................................................................ 148 10.6.1.3 Rest-of-Middle East ......................................................................................... 148 10.6.2 Africa .................................................................................................... 149 11.Company Profiles ..................................................................... 150 11.1 Overview .................................................................................................... 151 11.2 Bio-Rad Laboratories, Inc. ........................................................................ 152 11.2.1 Company Overview ............................................................................. 152 11.2.2 Role of Bio-Rad Laboratories, Inc. in the Global Digital PCR Market ................................................................................................... 152 11.2.3 Key Competitors of the Company ..................................................... 152 11.2.4 Key Customers of the Company ........................................................ 152 11.2.5 Synergistic Activities .......................................................................... 153 11.2.6 Business Strategies ............................................................................ 153 11.2.6.1 Product Launch/Approval ................................................................................ 153 11.2.7 Financials ............................................................................................. 154 11.2.8 Analyst Perspective ............................................................................ 156 11.3 Fluidigm Corporation ................................................................................ 157 11.3.1 Company Overview ............................................................................. 157 Global Digital PCR Market 11.3.2 Role of Fluidigm Corporation in the Global d- PCR Market ............. 157 11.3.3 Key Competitors of the Company ..................................................... 157 11.3.4 Key Customers of the Company ........................................................ 157 11.3.5 Corporate Strategies ........................................................................... 158 7 All rights reserved at BIS Research Inc.

  8. 11.3.5.1 Synergistic Activities ........................................................................................ 158 11.3.6 Financials ............................................................................................. 158 11.3.7 Analyst Perspective ............................................................................ 160 11.4 F. Hoffmann-La Roche Ltd........................................................................ 161 11.4.1 Company Overview ............................................................................. 161 11.4.2 Role of F. Hoffmann-La Roche Ltd. in the Global d-PCR Market .... 161 11.4.3 Key Competitors of the Company ..................................................... 161 11.4.4 Corporate Strategies ........................................................................... 162 11.4.4.1 Synergistic Activities ........................................................................................ 162 11.4.5 Financials ............................................................................................. 162 11.4.6 Analyst Perspective ............................................................................ 165 11.5 Merck KGaA ............................................................................................... 166 11.5.1 Company Overview ............................................................................. 166 11.5.2 Role of Merck KGaA in the Global Digital PCR Market .................... 166 11.5.3 Key Competitors of the Company ..................................................... 166 11.5.4 Financials ............................................................................................. 167 11.5.5 Analyst Perspective ............................................................................ 169 11.6 QIAGEN N.V. .............................................................................................. 170 11.6.1 Company Overview ............................................................................. 170 11.6.2 Role of QIAGEN N.V. in the Global Digital PCR Market ................... 170 11.6.3 Key Competitors of the Company ..................................................... 170 11.6.4 Corporate strategies ........................................................................... 171 11.6.4.1 Synergistic Activities ........................................................................................ 171 11.6.5 Business Strategies ............................................................................ 172 Global Digital PCR Market 11.6.5.1 Product Launch/Approval ................................................................................ 172 11.6.6 Financials ............................................................................................. 172 11.6.7 Analyst Perspective ............................................................................ 174 11.7 Thermo Fisher Scientific Inc. ................................................................... 175 8 All rights reserved at BIS Research Inc.

  9. 11.7.1 Company Overview ............................................................................. 175 11.7.2 Role of Thermo Fisher Scientific Inc. in the Global Digital PCR Market ................................................................................................... 175 11.7.3 Key Competitors of the Company ..................................................... 175 11.7.4 Corporate strategies ........................................................................... 176 11.7.4.1 Synergistic Activities ........................................................................................ 176 11.7.5 Business Strategies ............................................................................ 176 11.7.5.1 Product Launch/Approval ................................................................................ 176 11.7.6 Financials ............................................................................................. 177 11.7.7 Analyst Perspective ............................................................................ 179 11.8 Genetron Holdings Limited ...................................................................... 180 11.8.1 Company Overview ............................................................................. 180 11.8.2 Role of Genetron Holdings Limited in the Global Digital PCR Market ................................................................................................... 180 11.8.3 Key Competitors of the Company ..................................................... 180 11.8.4 Key Customers of the Company ........................................................ 180 11.8.5 Corporate Strategies ........................................................................... 181 11.8.5.1 Synergistic Activities ........................................................................................ 181 11.8.6 Financials ............................................................................................. 182 11.8.7 Analyst Perspective ............................................................................ 183 11.9 JN Medsys ................................................................................................. 184 11.9.1 Company Overview ............................................................................. 184 11.9.2 Role of JN Medsys in the Global Digital PCR Market ....................... 184 11.9.3 Key Competitors of the Company ..................................................... 184 Global Digital PCR Market 11.9.4 Analyst Perspective ............................................................................ 185 11.10 Stilla ............................................................................................................ 186 11.10.1 Company Overview ............................................................................. 186 11.10.2 Role of Stilla in the Global Digital PCR Market ................................. 186 11.10.3 Key Competitors of the Company ..................................................... 186 9 All rights reserved at BIS Research Inc.

  10. 11.10.4 Corporate Strategies ........................................................................... 186 11.10.4.1 Synergistic Activities ........................................................................................ 186 11.10.5 Business Strategies ............................................................................ 187 11.10.5.1 Product Launch/Approval ................................................................................ 187 11.10.6 Analyst Perspective ............................................................................ 188 11.11 Naveris, Inc. ............................................................................................... 189 11.11.1 Company Overview ............................................................................. 189 11.11.2 Role of Naveris, Inc. in the Global Digital PCR Market .................... 189 11.11.3 Key Competitors of the Company ..................................................... 189 11.11.4 Corporate strategies ........................................................................... 189 11.11.4.1 Synergistic Activities ........................................................................................ 189 11.11.5 Analyst Perspective ............................................................................ 190 11.12 SAGA Diagnostics ..................................................................................... 191 11.12.1 Company Overview ............................................................................. 191 11.12.2 Role of SAGA Diagnostics in the Global Digital PCR Market .......... 191 11.12.3 Key Competitors of the Company ..................................................... 191 11.12.4 Corporate strategies ........................................................................... 191 11.12.4.1 Synergistic Activities ........................................................................................ 191 11.12.5 Analyst Perspective ............................................................................ 192 11.13 Emerging Companies ............................................................................... 193 11.13.1 Precigenome LLC ................................................................................ 193 11.13.2 RevoSketch Inc. .................................................................................. 193 Global Digital PCR Market 10 All rights reserved at BIS Research Inc.

  11. List of Figures Figure 1:Global Digital PCR Market (by Product), $Million, 2021 and 2032 Figure 2:Global Digital PCR Market (by Application Type), $Million, 2021 and 2032 Figure 3:Global Digital PCR Market (by Region), $Million, 2021 and 2032 Figure 4:Global Digital PCR Market (by End User), $Million, 2021 and 2032 Figure 5:Global Digital PCR Market Segmentation Figure 6:Global Digital PCR Market: Research Methodology Figure 7:Primary Research Methodology Figure 8:Bottom-Up Approach (Segment-Wise Analysis) Figure 9:Top-Down Approach (Segment-Wise Analysis) Figure 10:Evolution of Digital PCR Figure 11:Global Digital PCR Market, $Million, 2021-2032 Figure 12:Pre-COVID-19 and Post-COVID-19 Scenario of Global Digital PCR Market, $Million, 2019- 2025 Figure 13:Components Considered for Clinical Actionability as per the IVDR Figure 14:Region-Wise Analysis of Patents, January 2020-July 2022 Figure 15:Country-Wise Analysis of Patents, January 2020-July 2022 Figure 16:Year-Wise Analysis of Patents, January 2020-July 2022 Figure 17:Global Digital PCR Market Dynamics Figure 18:Likert Scale Figure 19:Impact Analysis of Market Drivers and Challenges on the Global Digital PCR Market Figure 20:Share of Key Developments and Strategies, January 2019-January 2022 Figure 21:Share of Mergers and Acquisitions (by Company), January 2019-January 2022 Figure 22:Share of Synergistic Activities (by Company), January 2019-January 2022 Figure 23:Share of Product Launch and Approval Activities (by Company), January 2019-January 2022 Figure 24:Share of Expansion, Funding, and Other Activities (by Company), January 2019-January 2022 Figure 25:Market-Share Analysis for the Global Digital PCR Market, $Million, 2020 and 2021 Figure 26:Growth-Share Analysis of the Global Digital PCR Market (by Company), 2021 Figure 27:Growth-Share Analysis for Digital PCR Market (by Application Type), 2021 Figure 28:Supply Chain Analysis of the Global Digital PCR Market Figure 29:Global Digital PCR Market (by Product) Figure 30:Share of Global Digital PCR Market (by Product), $Million, 2021 and 2032 Figure 31:Digital PCR Systems Workflow Figure 32:Global Digital PCR Market (Systems), $Million, 2021-2032 Figure 33:Sample Partitioning of Droplet Digital PCR System Figure 34:Global Digital PCR Market (Droplet Digital PCR Systems), $Million, 2021-2032 Figure 35:Workflow of Chip-Based Digital PCR System Global Digital PCR Market 11 All rights reserved at BIS Research Inc.

  12. Figure 36:Global Digital PCR Market (Chip-Based Digital PCR Systems), $Million, 2021-2032 Figure 37:Global Digital PCR Market (Kits and Assays), $Million, 2021-2032 Figure 38:Global Digital PCR Market (Kits and Assays for Droplet Digital PCR Systems), $Million, 2021-2032 Figure 39:Global Digital PCR Market (Kits and Assays for Chip-Based Digital PCR Systems), $Million, 2021-2032 Figure 40:Global Digital PCR Market (Reagents and Consumables), $Million, 2021-2032 Figure 41:Global Digital PCR Market (Reagents and Consumables for Droplet Digital PCR Systems), $Million, 2021-2032 Figure 42:Global Digital PCR Market (Reagents and Consumables for Chip-Based Digital PCR), $Million, 2021-2032 Figure 43:Global Digital PCR Market (by Application Type) Figure 44:Share of Global Digital PCR Market (by Application Type), $Million, 2021 and 2032 Figure 45:Estimated New Breast Cancer Cases among Female Population Figure 46:Global Digital PCR Market (Oncology), $Million, 2021-2032 Figure 47:Global Digital PCR Market (Solid Tumor, by Oncology), $Million, 2021-2032 Figure 48:Global Digital PCR Market (Hematologic Malignancies, by Oncology), $Million, 2021-2032 Figure 49:Global Digital PCR Market (Infectious Diseases), $Million, 2021-2032 Figure 50:Distribution of Respiratory Infections Figure 51:Global Digital PCR Market (Respiratory Infections, by Infectious Diseases), $Million, 2021- 2032 Figure 52:Global Digital PCR Market (Gastrointestinal Infections, by Infectious Diseases), $Million, 2021-2032 Figure 53:Global Digital PCR Market (Other Infectious Diseases, by Infectious Diseases), $Million, 2021-2032 Figure 54:Global Burden of Rare Diseases Figure 55:Global Digital PCR Market (Rare Diseases), $Million, 2021-2032 Figure 56:Global Digital PCR Market (Inherited Trait Type, by Rare Diseases), $Million, 2021-2032 Figure 57:Global Digital PCR Market (Acquired Trait Type, by Rare Diseases), $Million, 2021-2032 Figure 58:Global Digital PCR Market (Reproductive Genetics), $Million, 2021-2032 Figure 59:Global Digital PCR Market (Prenatal Diseases, by Reproductive Genetics), $Million, 2021- 2032 Figure 60:Global Digital PCR Market (Postnatal Diseases, by Reproductive Genetics), $Million, 2021- 2032 Figure 61:Global Digital PCR Market (Gene Expression), $Million, 2021-2032 Figure 62:Global Digital PCR Market (Other Applications), $Million, 2021-2032 Figure 63:Global Digital PCR Market (by End User) Figure 64:Share of Global Digital PCR Market (by End User), $Million, 2021 and 2032 Figure 65:Global Digital PCR Market (Academic and Research Institutions), $Million, 2021-2032 Figure 66:Global Digital PCR Market (Hospitals and Clinics), $Million, 2021-2032 Global Digital PCR Market 12 All rights reserved at BIS Research Inc.

  13. Figure 67:Global Digital PCR Market (Diagnostic Centers), $Million, 2021-2032 Figure 68:Global Digital PCR Market (Biopharmaceutical Companies), $Million, 2021-2032 Figure 69:Global Digital PCR Market Snapshot (by Region) Figure 70:Global Digital PCR Market (by Region), $Million, 2021-2032 Figure 71:Share of Global Digital PCR Market (by Region), $Million, 2021 and 2032 Figure 72:North America Digital PCR Market, $Million, 2021-2032 Figure 73:Growth Potential Analysis (by Country), $Million, 2021-2032 Figure 74:U.S. Digital PCR Market, $Million, 2021-2032 Figure 75:U.S. Digital PCR Market (by End User), $Million, 2021-2032 Figure 76:Canada Digital PCR Market, $Million, 2021-2032 Figure 77:Canada Digital PCR Market (by End User), $Million, 2021-2032 Figure 78:Europe Digital PCR Market, $Million, 2021-2032 Figure 79:Growth Potential Analysis (by Country), $Million, 2021–2032 Figure 80:Germany Digital PCR Market, $Million, 2021-2032 Figure 81:Germany Digital PCR Market (by End User), $Million, 2021-2032 Figure 82:France Digital PCR Market, $Million, 2021-2032 Figure 83:France Digital PCR Market (by End User), $Million, 2021-2032 Figure 84:U.K. Digital PCR Market, $Million, 2021-2032 Figure 85:U.K. Digital PCR Market (by End User), $Million, 2021-2032 Figure 86:Italy Digital PCR Market, $Million, 2021-2032 Figure 87:Italy Digital PCR Market (by End User), $Million, 2021-2032 Figure 88:Spain Digital PCR Market, $Million, 2021-2032 Figure 89:Spain Digital PCR Market (by End User), $Million, 2021-2032 Figure 90:Rest-of-Europe Digital PCR Market, $Million, 2021-2032 Figure 91:Rest-of-Europe Digital PCR Market (by End User), $Million, 2021-2032 Figure 92:Asia-Pacific Digital PCR Market, $Million, 2021-2032 Figure 93:Growth Potential Analysis (by Country), $Million, 2021-2032 Figure 94:Japan Digital PCR Market, $Million, 2021-2032 Figure 95:Japan Digital PCR Market (by End User), $Million, 2021-2032 Figure 96:China Digital PCR Market, $Million, 2021-2032 Figure 97:China Digital PCR Market (by End User), $Million, 2021-2032 Figure 98:Australia Digital PCR Market, $Million, 2021-2032 Figure 99:Australia Digital PCR Market (by End User), $Million, 2021-2032 Figure 100: South Korea Digital PCR Market, $Million, 2021-2032 Figure 101: South Korea Digital PCR Market (by End User), $Million, 2021-2032 Figure 102: Rest-of-Asia-Pacific Digital PCR Market, $Million, 2021-2032 Figure 103: Rest-of-Asia-Pacific Digital PCR Market (by End User), $Million, 2021-2032 Figure 104: Latin America Digital PCR Market, $Million, 2021-2032 Figure 105: Growth Potential Analysis (by Country), $Million, 2021-2032 Figure 106: Brazil Digital PCR Market, $Million, 2021-2032 Global Digital PCR Market 13 All rights reserved at BIS Research Inc.

  14. Figure 107: Figure 108: Figure 109: Figure 110: Figure 111: Figure 112: Figure 113: Figure 114: Figure 115: Figure 116: Figure 117: Figure 118: Figure 119: Figure 120: Figure 121: Figure 122: Figure 123: Figure 124: Figure 125: Figure 126: Figure 127: Figure 128: Figure 129: Figure 130: Figure 131: Figure 132: Figure 133: Figure 134: Figure 135: Figure 136: Figure 137: Figure 138: Figure 139: Figure 140: Figure 141: Figure 142: Figure 143: Figure 144: Figure 145: Figure 146: Brazil Digital PCR Market (by End User), $Million, 2021-2032 Mexico Digital PCR Market, $Million, 2021-2032 Mexico Digital PCR Market (by End User), $Million, 2021-2032 Rest-of-Latin America Digital PCR Market, $Million, 2021-2032 Rest-of-Latin America Digital PCR Market (by End User), $Million, 2021-2032 Rest-of-the-World Digital PCR Market, $Million, 2021-2032 Middle East Digital PCR Market, $Million, 2021-2032 K.S.A. Digital PCR Market, $Million, 2021-2032 Turkey Digital PCR Market, $Million, 2021-2032 Egypt Digital PCR Market, $Million, 2021-2032 Rest-of-Middle East Digital PCR Market, $Million, 2021-2032 Africa Digital PCR Market, $Million, 2021-2032 Total Number of Companies Profiled Bio-Rad Laboratories, Inc.: Product Portfolio Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2019-2021 Bio-Rad Laboratories, Inc.: Revenue (by Segment), $Million, 2019-2021 Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2019-2021 Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2019-2021 Fluidigm Corporation: Product Portfolio Fluidigm Corporation: Overall Financials, $Million, 2019-2021 Fluidigm Corporation: Revenue (by Region), $Million, 2019-2021 Fluidigm Corporation: R&D Expenditure, $Million, 2019-2021 F. Hoffmann-La Roche Ltd.: Product Portfolio F. Hoffmann-La Roche Ltd.: Overall Financials, $Million, 2019-2021 F. Hoffmann-La Roche Ltd.: Revenue (by Segment), $Million, 2019-2021 F. Hoffmann-La Roche Ltd.: Revenue (by Region), $Million, 2019-2021 F. Hoffmann-La Roche Ltd.: R&D Expenditure, $Million, 2019-2021 Merck KGaA: Product Portfolio Merck KGaA: Overall Financials, $Million, 2019-2021 Merck KGaA: Revenue (by Segment), $Million, 2019-2021 Merck KGaA: Revenue (by Region), $Million, 2019-2021 Merck KGaA: R&D Expenditure, $Million, 2019-2021 QIAGEN N.V.: Product Profile QIAGEN N.V.: Overall Financials, $Million, 2019-2021 QIAGEN N.V.: Revenue (by Segment), $Million, 2019-2021 QIAGEN N.V.: Revenue (by Region), $Million, 2019-2021 QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021 Thermo Fisher Scientific Inc.: Product Portfolio Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2019-2021 Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2019-2021 Global Digital PCR Market 14 All rights reserved at BIS Research Inc.

  15. Figure 147: Figure 148: Figure 149: Figure 150: Figure 151: Figure 152: Figure 153: Figure 154: Figure 155: Figure 156: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2019-2021 Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2019-2021 Genetron Holdings Limited: Product Portfolio Genetron Holdings Limited: Overall Financials, $Million, 2019-2021 Genetron Holdings Limited: Revenue (by Segment), $Million, 2019-2021 Genetron Holdings Limited: R&D Expenditure, $Million, 2019-2021 JN Medsys: Product Portfolio Stilla: Product Portfolio Naveris, Inc.: Product Portfolio SAGA Diagnostics: Product Portfolio Global Digital PCR Market 15 All rights reserved at BIS Research Inc.

  16. List of Tables Table 1: Table 2: Table 3: Table 4: Table 5: Table 6: Table 7: Table 8: Table 9: Table 10:Companies Providing Kits and Assays for Digital PCR Systems Table 11:Companies Providing Reagents and Consumables for Digital PCR Systems Table 12:Hematologic Malignancies and Their Targets Using Droplet Digital PCR Systems Table 13:North America: Market Dynamics Table 14:Europe: Market Dynamics Table 15:Asia-Pacific: Market Dynamics Table 16:Latin America: Market Dynamics Non-Invasive Prenatal Testing Performance by Digital PCR Advantages of Digital PCR over Conventional PCR Digital PCR Diagnostics Solutions Offered for COVID-19 Registration Criteria for IVD Medical Devices as per the CFDA Different Technology-Based Products Different Application-Based Products Companies Providing Digital PCR Systems Companies Providing Droplet Digital PCR Systems Companies Providing Chip-Based Digital PCR Systems Global Digital PCR Market 16 All rights reserved at BIS Research Inc.

  17. Disclaimer BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce Information in legal proceedings. Market reports are based on expectations, estimates and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties and contingencies For more details regarding permission, please contact us: Email: sales@bisresearch.com Tel: +1 510 404 8135 Global Digital PCR Market 17 All rights reserved at BIS Research Inc.

  18. BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686 E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135 Global Digital PCR Market Global Delivery Center Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway, Sector 126, Noida, U.P., 201303, India Tel: +91 120 4261540 / 4261544 18 www.bisresearch.com All rights reserved at BIS Research Inc.

More Related